Parenteral Drug Association
Connecting People, Science and Regulation ®
by: Christoph Bredack, PhD, Genedata
by: Lucia Ceresa
by: Parampal Deol
John Shabushnig, PhD, Insight Pharma Consulting, LLC
Claire Briglia, Vedere Solutions
Justin Ratzan-Wank, Master of Business and Science Candidate, Keck Graduate Institute
Tia Bush, Amgen, Inc.
Martin Van Trieste, President & CEO, Civica Rx
Jason Kerr, Redica Systems
PDA Europe
Jette Christensen (Novo Nordisk), Chair PDA Board of Directors
Richard Johnson, PDA
Ziva Abraham, Microlite, Inc.
Michael De Felippis, Eli Lilly and Cristiana Campa, GSK Vaccines
Walter Morris, PDA
Marilyn Foster, PDA
Hal Baseman, ValSource, Gabriele Gori, GSK Vaccines, and Jahanvi Miller, PDA
Ali Ardakani, Novateur Ventures and Fenton Fong, xCellarate Technology
Tony Manzano, Aizon; Andrej Ondrack, Aizon; Kir Henrici, The Henrici Group
Ajay Babu Pazhayattil, Industrial Pharmacist
Subrata Chakraborty, GxPFONT Consulting Group
Fran DeGrazio and Diane Paskiet, West Pharmaceuticals Services, Inc.
Christine Roberts, PDA
Anna Gilbert, BDO; Robert Greathead, Catalent Pharma Solutions; Michelle Bernards, Manager, Catalent Pharma Solutions
Glenn Wright, PDA
West Coast Chapter
Marilyn L. Foster, PDA
Robert Schaut, Kelly Murphy (formerly), Daniel Kramer, Christy Chapman, and Carol Rea Flynn, Corning Inc.
Michael J. Miller, PhD
Hal Baseman, Valsource, Inc and Annex 1 Response Team Co-Chair
PDA
Michael Blackton, Adaptimmune, LLC, and Stephan Krause, PhD, AstraZeneca Diagnostics; ATMP Advisory Board Co-Chairs
Kevin T. Moore, PhD, U. S. Pharmacopeia, and J. Mark Wiggins, Global Pharmacopoeia Solutions LLC
Brianna Kempker, Steris Corporation
Brian J. Hawkins, Raluca Marcu, Pluristyx, Inc.
Walt Morris, PDA
Matthew Paquette, Charles River
Kir Henrici, The Henrici Group, and Monica Cahilly, Green Mountain Quality Assurance, LLC
Rebecca Stauffer, PDA
Christy Wong, PDA Southern California Student Chapter President and Student, Keck Graduate Institute
Bernhard Hinsch, Hinsch Consulting
Angela Molaschi, Chapter President
Oliver Stauffer, PTI
Kevin Williams, bioMerieux
Gabriele Peron, Stevanato Group
Els Poff, Merck, and Technical Report Team Leader
Anil Sawant, PhD, Merck
William Peterson, Merck & Co.
Marten Ritz and Thomas Friedli, University of St. Gallen, Switzerland
Vladislav Shestakov, Russian State Institute of Drugs and Good Practices, and Elizabeth Meyers, Amgen
Satya Moturi, PhD, Biological E. Ltd
Anthony Grilli, Focus Laboratories, and PDA Metro Chapter President
Bettine Boltres, PhD, West Pharmaceutical Services, Inc.
PDA Capital Area Chapter
Thomas R. Kreil, Takeda
PDA Letter editors
Dawn MacNeill, MilliporeSigma
Sunil Anklekar, PhD, Lantheus Medical Imaging, and Treasurer, PDA New England Chapter, and Jacklyn Chesny
Walid El Azab, STERIS, and Stephane Cousin, GSK
John D. Ayres, MD, Pharma Safety Solutions, LLC
Aidan Harrington, Senior Consultant DPS Global, and President-Elect, PDA Ireland Chapter
Dawn Watson and Jeff Cremi, Merck & Co., Inc.
Stephanie Gaulding, Pharmatech Associates
PDA Singapore Chapter
Walid El Azab, STERIS, and Stephane Cousin, GSK Vaccines
Stephan Krause, Mariam Khan, Callum Chapman, Rob Gaglione, Andy Spasoff, Anthony Mire-Sluis (all AstraZeneca)
Susan Schniepp, Regulatory Compliance Associates
Tony Manzano, bigfinite
Ivy Louis, Vienni Training and Consulting
Hal Baseman, ValSource
Martin VanTrieste, President & CEO, Civica Rx
Tony Cundell, PhD, Microbiological Consulting, and Michael Miller, PhD, Microbiology Consultants
Pascal Sircoulomb, ARaymondlife, and Luce Sohier, SCHOTT